Arcutis Biotherapeutics (ARQT) Institutional Ownership

Of the 258 institutional investors that purchased Arcutis Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BlackRock Inc. ($10.55M), Bank of America Corp DE ($4.22M), Suvretta Capital Management LLC ($2.88M), Perpetual Ltd ($2.02M), Jennison Associates LLC ($1.91M), Bamco Inc. NY ($1.76M), and Point72 Asset Management L.P. ($1.75M).

Institutional investors have bought a total of 42,285,004 shares in the last 24 months. This purchase volume represents approximately $1.09B in transactions.

Of the 78 institutional investors that sold Arcutis Biotherapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Jennison Associates LLC ($7.27M), Rubric Capital Management LP ($2.48M), Perpetual Ltd ($1.11M), Suvretta Capital Management LLC ($1.06M), JPMorgan Chase & Co. ($895.99K), Franklin Resources Inc. ($832.69K), and Millennium Management LLC ($760.74K).

Institutional investors have sold a total of 21,141,831 shares in the last 24 months. This volume of shares sold represents approximately $547.02M in transactions.